Since a temporal and causal relationship between FSTL3 expression and breast carcinogenesis in humans cannot be properly investigated in vivo, we speculate that this protein is constitutively expressed in invasive breast cancers and is down-regulated by still unknown mechanisms in high nuclear grade lesions. The gene discussed is FSTL3; the disease is invasive breast carcinoma.